speb/financial-data huggingface dataset:
Financial ratios for MCB.TO — annual report dated 2023-12-31
Total revenue: 52794696.96969697
Gross profit: 17295454.545454543
Operating income: 5856818.181818182
Net income: 4946212.121212121
Capital expenditures: 3342424.242424242
Operating cash flow: 5106818.181818182
Depreciation & amortization: 2884848.484848485
Net tangible assets: 34133333.33333333
Owner earnings: 4488636.363636363
Return on net tangible assets (%): 13.150301846590908
Capex to operating income (%): 57.0689432156254
Buffett classification: The Good
Stock price: 1.477272727272727
P/E ratio: 8.108173173533466
Shares outstanding: 27147827
Book value: 40896212.12121212
P/B ratio: 0.980646919400552
Market cap (USD): 40104744.43181818
Debt to equity: 0.07987699831428413
Current ratio: 2.8802493765586035
Quick ratio: 1.354513715710723
Effective tax rate (%): 7.8735713277832655
Interest coverage ratio: 11.385861561119293
COGS to revenue (%): 67.24016702779491
R&D to revenue (%): 5.845972822109659
SG&A to revenue (%): 15.820287276327683
Free cash flow (dilution-adjusted): 675000
Buyback yield (%): 4.892491499246434
Retained earnings: -13903030.303030303
Inventory turnover: 1.5317903958680656
Receivables turnover: 6.694428434197887
Capitalized R&D asset: 4544598.930481283
ROCI (R&D-adjusted, %): 15.017205847772699
Rosenberg metric: 2.6212223587223584
FCF margin (%): 1.2785375023317884
Revenue growth (%): 36.95122430530991
Rule of 40 score: 38.229761807641694
Financial ratios for MCB.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.711111111111111
Shares outstanding: 27147827
Market cap (USD): 46452948.42222222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCB.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.93006993006993
Shares outstanding: 27147827
Market cap (USD): 52397204.55944056
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCB.TO — annual report dated 2024-12-31
Total revenue: 54206993.00699301
Gross profit: 19320279.72027972
Operating income: 6945454.545454546
Net income: 6203496.503496503
Capital expenditures: 1371328.6713286713
Operating cash flow: 4551048.951048952
Depreciation & amortization: 3009790.20979021
Net tangible assets: 39819580.41958042
Owner earnings: 7841958.0419580415
Return on net tangible assets (%): 19.693723437884163
Capex to operating income (%): 19.744260974627466
Buffett classification: The Great
Stock price: 1.93006993006993
P/E ratio: 8.446398660804869
Shares outstanding: 27147827
Book value: 46290209.7902098
P/B ratio: 1.1319284314525264
Market cap (USD): 52397204.55944056
Debt to equity: 0.06017070775738348
Current ratio: 2.583038747983663
Quick ratio: 1.200981569825308
Effective tax rate (%): 10.393939393939396
Interest coverage ratio: 25.7974025974026
COGS to revenue (%): 64.3583260230146
R&D to revenue (%): 6.058104133340214
SG&A to revenue (%): 16.77073120388049
Free cash flow (dilution-adjusted): 925174.8251748253
Buyback yield (%): 0
Retained earnings: -8148251.748251748
Inventory turnover: 1.238868608607117
Receivables turnover: 4.720828258221681
Capitalized R&D asset: 6070015.014397368
ROCI (R&D-adjusted, %): 13.637110366096836
Rosenberg metric: 0.6560552849212649
FCF margin (%): 1.706744414056453
Revenue growth (%): 2.675071774929724
Rule of 40 score: 4.381816188986177
Financial ratios for MCB.TO — quarterly report dated 2025-03-31
Total revenue: 13528671.328671329
Gross profit: 4620979.020979021
Operating income: 913986.0139860141
Net income: 661538.4615384616
Capital expenditures: 1161538.4615384615
Operating cash flow: -1916783.216783217
Depreciation & amortization: 799300.6993006993
Net tangible assets: 39720979.020979024
Owner earnings: 299300.6993006994
Return on net tangible assets (%): 0.7535078607770992
Capex to operating income (%): 127.08492731446057
Buffett classification: The Gruesome
Stock price: 2.202797202797203
P/E ratio: 22.59927459038055
Shares outstanding: 27147827
Book value: 46035664.33566433
P/B ratio: 1.2990180165879297
Market cap (USD): 59801157.37762238
Debt to equity: 0.06384530084610594
Current ratio: 2.7685077790665122
Quick ratio: 1.0881094268687759
Effective tax rate (%): 13.13131313131313
Interest coverage ratio: 29.704545454545457
COGS to revenue (%): 65.84306833453944
R&D to revenue (%): 7.076398221854646
SG&A to revenue (%): 20.324614907474412
Free cash flow (dilution-adjusted): -3862237.7622377626
Buyback yield (%): 1.1389727406408963
Retained earnings: -7956643.356643357
Inventory turnover: 0.3031774366297751
Receivables turnover: 1.2478070175438596
Capitalized R&D asset: 957342.6573426573
ROCI (R&D-adjusted, %): 3.186063424623452
FCF margin (%): -28.548537165305493
Rule of 40 score: -28.548537165305493
Financial ratios for MCB.TO — quarterly report dated 2025-06-30
Total revenue: 17555474.452554744
Gross profit: 6352554.744525547
Operating income: 1438686.1313868612
Net income: 997810.2189781021
Capital expenditures: 774452.5547445255
Operating cash flow: -598540.1459854015
Depreciation & amortization: 884671.5328467153
Net tangible assets: 39607299.27007299
Owner earnings: 1108029.1970802918
Return on net tangible assets (%): 2.7975378718071577
Capex to operating income (%): 53.83054287163876
Buffett classification: The Good
Stock price: 2.875912408759124
P/E ratio: 47.05145666903528
Shares outstanding: 27147827
Book value: 45787591.2408759
P/B ratio: 1.7051513395718092
Market cap (USD): 78074772.54014598
Debt to equity: 0.058537518532098404
Current ratio: 2.3564703590675933
Quick ratio: 0.9808129342250503
Effective tax rate (%): 20.845396641574983
Interest coverage ratio: 50.53846153846154
COGS to revenue (%): 63.814394411874765
R&D to revenue (%): 6.182695106232589
SG&A to revenue (%): 21.80782503845994
Free cash flow (dilution-adjusted): -2654744.525547445
Buyback yield (%): 0.3833121292012939
Retained earnings: -7795620.437956204
Inventory turnover: 0.36221178580699975
Receivables turnover: 1.1632327336041788
Capitalized R&D asset: 1726821.040273595
ROCI (R&D-adjusted, %): 3.762376264652108
Rosenberg metric: 1.8087313985913314
FCF margin (%): -15.12203234792732
Revenue growth (%): 29.76495641038604
Rule of 40 score: 14.642924062458722
Financial ratios for MCB.TO — quarterly report dated 2025-09-30
Total revenue: 10667625.899280576
Gross profit: 2379136.6906474824
Operating income: 270503.59712230216
Net income: 398561.1510791367
Capital expenditures: 746762.5899280576
Operating cash flow: 229496.40287769787
Depreciation & amortization: 945323.7410071943
Net tangible assets: 39244604.31654677
Owner earnings: 597122.3021582734
Return on net tangible assets (%): 1.52153987167736
Capex to operating income (%): 276.06382978723406
Buffett classification: The Gruesome
Stock price: 2.6762589928057556
P/E ratio: 35.305053228473376
Shares outstanding: 27147827
Book value: 46130935.25179857
P/B ratio: 1.5749651670253577
Market cap (USD): 72654616.1438849
Debt to equity: 0.052945946788933586
Current ratio: 2.555580390403815
Quick ratio: 0.7796900610937267
Effective tax rate (%): -218.39080459770116
Interest coverage ratio: 2.6478873239436616
COGS to revenue (%): 77.69759913676828
R&D to revenue (%): 5.847046128945239
SG&A to revenue (%): 13.919611545724306
Free cash flow (dilution-adjusted): -1582014.3884892086
Buyback yield (%): 0
Retained earnings: -7766906.4748201445
Inventory turnover: 0.2416722604463836
Receivables turnover: 0.9545513068108664
Capitalized R&D asset: 1666883.0622195113
ROCI (R&D-adjusted, %): 0.011053534913254398
Rosenberg metric: -3.660781932624714
FCF margin (%): -14.830051254383598
Revenue growth (%): -39.234761623157496
Rule of 40 score: -54.064812877541094
Financial ratios for MCB.TO — quarterly report dated 2025-12-31
Total revenue: 18652554.744525544
Gross profit: 6913138.686131386
Operating income: 4926277.372262773
Net income: 4487591.240875912
Capital expenditures: 343065.6934306569
Operating cash flow: 1102189.7810218977
Depreciation & amortization: 1017518.2481751824
Net tangible assets: 43175182.48175182
Owner earnings: 5162043.795620438
Return on net tangible assets (%): 11.956043956043956
Capex to operating income (%): 6.963994665876426
Buffett classification: The Great
Stock price: 2.145985401459854
P/E ratio: 8.90059290775715
Shares outstanding: 27147827
Book value: 50079562.043795615
P/B ratio: 1.163325677097757
Market cap (USD): 58258840.42335766
Debt to equity: 0.04688889212785495
Current ratio: 3.098251494836021
Quick ratio: 1.117276680558072
Effective tax rate (%): 7.228006639505054
Interest coverage ratio: 22.57190635451505
COGS to revenue (%): 62.9373092275182
R&D to revenue (%): 5.842529545276669
SG&A to revenue (%): 4.809423182280661
Free cash flow (dilution-adjusted): 1504379.5620437956
Buyback yield (%): 0
Retained earnings: -3881751.824817518
Inventory turnover: 0.3677627366688009
Receivables turnover: 1.2583218436084302
Capitalized R&D asset: 1865869.9784697788
ROCI (R&D-adjusted, %): 9.595714229793352
Rosenberg metric: 7.269045875112601
FCF margin (%): 8.065273538389295
Revenue growth (%): 74.85197663130904
Rule of 40 score: 82.91725016969833
Financial ratios for MCB.TO — annual report dated 2025-12-31
Total revenue: 61152554.744525544
Gross profit: 20502919.708029196
Operating income: 7593430.656934306
Net income: 6580291.970802919
Capital expenditures: 3087591.2408759124
Operating cash flow: -1264233.5766423356
Depreciation & amortization: 3695620.437956204
Net tangible assets: 43175182.48175182
Owner earnings: 7188321.16788321
Return on net tangible assets (%): 16.649196956889263
Capex to operating income (%): 40.66134768816688
Buffett classification: The Good
Stock price: 2.145985401459854
P/E ratio: 8.853534262895176
Shares outstanding: 27147827
Book value: 50079562.043795615
P/B ratio: 1.163325677097757
Market cap (USD): 58258840.42335766
Debt to equity: 0.04688889212785495
Current ratio: 3.098251494836021
Quick ratio: 1.117276680558072
Effective tax rate (%): 6.259748362275137
Interest coverage ratio: 19.853053435114504
COGS to revenue (%): 66.47250504302987
R&D to revenue (%): 6.225903866123969
SG&A to revenue (%): 14.884398238221989
Free cash flow (dilution-adjusted): -6786861.313868612
Buyback yield (%): 1.7340183408407897
Retained earnings: -3881751.824817518
Inventory turnover: 1.273438214579713
Receivables turnover: 4.125418554264329
Capitalized R&D asset: 7026023.046296769
ROCI (R&D-adjusted, %): 13.775755162013265
Rosenberg metric: 0.3601310013802706
FCF margin (%): -11.098246577304574
Revenue growth (%): 12.813036385612678
Rule of 40 score: 1.7147898083081046
Financial ratios for MCM.AX — annual report dated 2021-06-30
Total revenue: 15564661.654135337
Gross profit: 2204511.2781954887
Operating income: -8729323.308270676
Net income: -8830075.187969925
Capital expenditures: 181203.00751879698
Depreciation & amortization: 1971428.5714285714
Net tangible assets: 80635338.34586465
Owner earnings: -7039849.624060151
Return on net tangible assets (%): -8.730476945312137
Buffett classification: The Gruesome
Stock price: 0.06015037593984962
Shares outstanding: 844925202
Book value: 80093233.08270675
P/B ratio: 0.6345426022304834
Market cap (USD): 50822568.54135338
Debt to equity: 0.22621193346100413
Current ratio: 0.21358337845925843
Quick ratio: 0.1898138911847693
Interest coverage ratio: -8.118881118881118
COGS to revenue (%): 85.8364330225593
SG&A to revenue (%): 23.124486739771026
Free cash flow (dilution-adjusted): -1279699.2481203007
Buyback yield (%): 0
Retained earnings: -682106766.9172932
Inventory turnover: 21.305755395683455
Receivables turnover: 6.035276967930029
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.700058484418081
FCF margin (%): -8.22182503260712
Rule of 40 score: -8.22182503260712
Financial ratios for MCM.AX — annual report dated 2022-06-30
Total revenue: 16214482.75862069
Gross profit: 3464137.931034483
Operating income: -13455172.413793104
Net income: -14297931.034482758
Capital expenditures: 700000
Operating cash flow: -1626206.8965517243
Depreciation & amortization: 1806896.551724138
Net tangible assets: 53765517.24137931
Owner earnings: -13191034.48275862
Return on net tangible assets (%): -24.534376603386352
Buffett classification: The Gruesome
Stock price: 0.06206896551724138
Shares outstanding: 844925202
Book value: 53197241.37931035
P/B ratio: 0.9858336986621032
Market cap (USD): 52443633.22758621
Debt to equity: 0.33871344119477287
Current ratio: 0.25134052206705554
Quick ratio: 0.12038182782393494
Interest coverage ratio: -13.63382250174703
COGS to revenue (%): 78.6355323040279
SG&A to revenue (%): 23.036025690102505
Free cash flow (dilution-adjusted): -2968275.8620689656
Buyback yield (%): 0
Retained earnings: -638789655.1724138
Inventory turnover: 4.159280089988751
Receivables turnover: 21.510521500457454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.328698085773944
FCF margin (%): -18.306324699077027
Revenue growth (%): 4.174977387399257
Rule of 40 score: -14.131347311677771
Financial ratios for MCM.AX — annual report dated 2023-06-30
Total revenue: 29668211.9205298
Gross profit: 4413907.284768212
Operating income: -3340397.3509933776
Net income: -2857615.894039735
Capital expenditures: 1001986.7549668874
Operating cash flow: -2343046.357615894
Depreciation & amortization: 1349006.6225165562
Net tangible assets: 58115894.0397351
Owner earnings: -2510596.026490066
Return on net tangible assets (%): -4.31998176742066
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 844925202
Book value: 57848344.37086092
P/B ratio: 1.2574587155270118
Market cap (USD): 72741904.80794701
Debt to equity: 0.21578459319298007
Current ratio: 0.6311710790291492
Quick ratio: 0.47035915188230204
Interest coverage ratio: -3.652425778421434
COGS to revenue (%): 85.12243576865555
SG&A to revenue (%): 18.272729301993348
Free cash flow (dilution-adjusted): -8221854.304635762
Buyback yield (%): 1.5449706226002895
Retained earnings: -616341721.8543047
Inventory turnover: 9.328277886497064
Receivables turnover: 10.049125168236877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.094229098915306
FCF margin (%): -27.71267215786067
Revenue growth (%): 82.97353274964149
Rule of 40 score: 55.260860591780826
Financial ratios for MDNA.TO — annual report dated 2022-03-31
Total revenue: 0
Operating income: -17978400
Net income: -18061600
Capital expenditures: 0
Operating cash flow: -18867200
Depreciation & amortization: 30400
Net tangible assets: 16616000
Owner earnings: -18031200
Return on net tangible assets (%): -108.51709195955705
Buffett classification: The Gruesome
Stock price: 1.3199999999999998
Shares outstanding: 92300201
Book value: 16668000
P/B ratio: 7.309591151907846
Market cap (USD): 121836265.31999998
Debt to equity: 0
Current ratio: 8.924456314383823
Quick ratio: 8.924456314383823
Free cash flow (dilution-adjusted): -19999200
Buyback yield (%): 0
Retained earnings: -56746400
Receivables turnover: 0
Capitalized R&D asset: 11772800
ROCI (R&D-adjusted, %): -35.61737597629696
Rule of 40 score: 0
Financial ratios for MDNA.TO — annual report dated 2023-03-31
Total revenue: 0
Operating income: -12076296.296296295
Net income: -7442962.962962963
Capital expenditures: 0
Operating cash flow: -9375555.555555554
Depreciation & amortization: 3703.7037037037035
Net tangible assets: 21796296.296296295
Owner earnings: -7439259.259259259
Return on net tangible assets (%): -34.13084112149533
Buffett classification: The Gruesome
Stock price: 0.6518518518518518
Shares outstanding: 92300201
Book value: 21841481.481481478
P/B ratio: 2.754669228786543
Market cap (USD): 60166056.948148146
Debt to equity: 0
Current ratio: 9.575
Quick ratio: 9.575
Free cash flow (dilution-adjusted): -10391111.11111111
Buyback yield (%): 0
Retained earnings: -59985925.925925925
Receivables turnover: 0
Capitalized R&D asset: 14779627.851851853
ROCI (R&D-adjusted, %): -29.274777866152075
Rule of 40 score: 0
Financial ratios for MDNA.TO — annual report dated 2024-03-31
Total revenue: 0
Operating income: -13832592.592592591
Net income: -18863703.7037037
Capital expenditures: 0
Operating cash flow: -12044444.444444444
Depreciation & amortization: 3703.7037037037035
Net tangible assets: 3802962.9629629627
Owner earnings: -18859999.999999996
Return on net tangible assets (%): -495.92910011686786
Buffett classification: The Gruesome
Stock price: 1.3676470588235294
Shares outstanding: 92300201
Book value: 3845185.1851851847
P/B ratio: 32.82913366899159
Market cap (USD): 126234098.4264706
Debt to equity: 0
Current ratio: 6.663290254977296
Quick ratio: 6.663290254977296
Free cash flow (dilution-adjusted): -12940000
Buyback yield (%): 0
Retained earnings: -78849629.62962963
Receivables turnover: 0
Capitalized R&D asset: 16502564.740740739
ROCI (R&D-adjusted, %): -51.55219319824636
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2024-09-30
Capital expenditures: 1481.4814814814813
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 92300201
Market cap (USD): 129220281.39999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -3580419.5804195805
Net income: -3630069.9300699304
Capital expenditures: 0
Operating cash flow: -2486013.986013986
Depreciation & amortization: 14685.314685314686
Net tangible assets: 12166433.566433568
Owner earnings: -3615384.6153846155
Return on net tangible assets (%): -29.71605931716289
Buffett classification: The Gruesome
Stock price: 1.1538461538461537
Shares outstanding: 92300201
Book value: 12203496.503496503
P/B ratio: 8.727026052948254
Market cap (USD): 106500231.92307691
Debt to equity: 0.009970775313735603
Current ratio: 10.085381222432263
Quick ratio: 10.085381222432263
Free cash flow (dilution-adjusted): -2925874.125874126
Buyback yield (%): 0
Retained earnings: -83523776.22377622
Receivables turnover: 0
Capitalized R&D asset: 2511888.111888112
ROCI (R&D-adjusted, %): -8.345326678302762
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3999300.6993006994
Net income: 830069.9300699302
Capital expenditures: 0
Operating cash flow: -3493706.2937062937
Depreciation & amortization: 13286.713286713288
Net tangible assets: 13316783.216783218
Owner earnings: 843356.6433566434
Return on net tangible assets (%): 6.333035761172084
Buffett classification: The Gruesome
Stock price: 0.6853146853146853
P/E ratio: 19.05101031592249
Shares outstanding: 92300201
Book value: 13353146.853146855
P/B ratio: 4.737061899973814
Market cap (USD): 63254683.202797204
Debt to equity: 0.008798114689709348
Current ratio: 6.351972942502818
Quick ratio: 6.351972942502818
Free cash flow (dilution-adjusted): -3840559.4405594403
Buyback yield (%): 0
Retained earnings: -82693706.2937063
Receivables turnover: 0
Capitalized R&D asset: 4825622.377622378
ROCI (R&D-adjusted, %): -12.708697758834495
Rule of 40 score: 0
Financial ratios for MDNA.TO — annual report dated 2025-03-31
Total revenue: 0
Operating income: -14269930.069930071
Net income: -8255244.755244755
Capital expenditures: 23076.923076923078
Operating cash flow: -11532867.132867133
Depreciation & amortization: 38461.53846153846
Net tangible assets: 13316783.216783218
Owner earnings: -8239860.13986014
Return on net tangible assets (%): -61.87575487055611
Buffett classification: The Gruesome
Stock price: 0.6853146853146853
Shares outstanding: 92300201
Book value: 13353146.853146855
P/B ratio: 4.737061899973814
Market cap (USD): 63254683.202797204
Debt to equity: 0.008798114689709348
Current ratio: 6.351972942502818
Quick ratio: 6.351972942502818
Free cash flow (dilution-adjusted): -13104195.804195806
Buyback yield (%): 0
Retained earnings: -82693706.2937063
Receivables turnover: 0
Capitalized R&D asset: 17735010.411810413
ROCI (R&D-adjusted, %): -36.25191150709852
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -4021167.8832116784
Net income: -3597080.2919708025
Capital expenditures: 0
Operating cash flow: -2588321.1678832113
Depreciation & amortization: 13868.61313868613
Net tangible assets: 10650364.96350365
Owner earnings: -3583211.6788321165
Return on net tangible assets (%): -33.64402714001782
Buffett classification: The Gruesome
Stock price: 0.6204379562043795
Shares outstanding: 92300201
Book value: 10686861.313868612
P/B ratio: 5.3585937333515465
Market cap (USD): 57266548.06569342
Debt to equity: 0.011064817976914146
Current ratio: 4.938320209973753
Quick ratio: 4.938320209973753
Free cash flow (dilution-adjusted): -2872992.7007299266
Buyback yield (%): 0
Retained earnings: -89912408.75912409
Receivables turnover: 0
Capitalized R&D asset: 6005306.416211526
ROCI (R&D-adjusted, %): -20.005758879836915
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -3935251.798561151
Net income: -3512949.64028777
Capital expenditures: 0
Operating cash flow: -3551798.5611510794
Depreciation & amortization: 16546.762589928057
Net tangible assets: 7333093.525179856
Owner earnings: -3496402.8776978417
Return on net tangible assets (%): -47.679780241342094
Buffett classification: The Gruesome
Stock price: 0.7050359712230216
Shares outstanding: 92300201
Book value: 7368345.323741008
P/B ratio: 8.831692733841047
Market cap (USD): 65074961.85611511
Debt to equity: 0.014547939855496973
Current ratio: 4.008073559093967
Quick ratio: 4.008073559093967
Free cash flow (dilution-adjusted): -3888489.2086330936
Buyback yield (%): 0
Retained earnings: -92131654.676259
Receivables turnover: 0
Capitalized R&D asset: 6049191.138274108
ROCI (R&D-adjusted, %): -25.515267842547207
Rule of 40 score: 0
Financial ratios for MDNA.TO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -4099270.0729927006
Net income: -3185401.459854014
Capital expenditures: 1459.85401459854
Operating cash flow: -3624087.5912408754
Depreciation & amortization: 13868.61313868613
Net tangible assets: 4499270.0729927
Owner earnings: -3172992.700729927
Return on net tangible assets (%): -70.5223880597015
Buffett classification: The Gruesome
Stock price: 0.6715328467153284
Shares outstanding: 92300201
Book value: 4534306.569343065
P/B ratio: 13.669701371538958
Market cap (USD): 61982616.729927
Debt to equity: 0.02173213135866066
Current ratio: 2.6775865643790167
Quick ratio: 2.6775865643790167
Free cash flow (dilution-adjusted): -3865693.4306569337
Buyback yield (%): 0
Retained earnings: -96662043.79562043
Receivables turnover: 0
Capitalized R&D asset: 5965990.757758756
ROCI (R&D-adjusted, %): -34.43290831500896
Rule of 40 score: 0
Financial ratios for MENE.V — annual report dated 2021-12-31
Total revenue: 21081306.299212597
Gross profit: 5135816.535433071
Operating income: 251001.5748031496
Net income: -25701.574803149604
Capital expenditures: 26254.33070866142
Operating cash flow: -800590.5511811024
Depreciation & amortization: 134518.89763779528
Net tangible assets: 12685406.2992126
Owner earnings: 82562.99212598425
Capex to operating income (%): 10.45982708644423
Buffett classification: The Great
Stock price: 0.6299212598425197
Shares outstanding: 150418163
Book value: 13874662.20472441
P/B ratio: 6.829110312169903
Market cap (USD): 94751598.74015749
Debt to equity: 0.5914068362648937
Current ratio: 2.294136580193448
Quick ratio: 0.7589230716094467
Interest coverage ratio: 0.8442390455129309
COGS to revenue (%): 75.63805362656821
R&D to revenue (%): 2.369584517148249
SG&A to revenue (%): 20.16363043438231
Free cash flow (dilution-adjusted): -883371.6535433071
Buyback yield (%): 0
Retained earnings: -14550886.614173228
Inventory turnover: 1.0925503209493743
Receivables turnover: 537.9288943360591
Capitalized R&D asset: 499539.3700787402
ROCI (R&D-adjusted, %): 4.063027907901783
FCF margin (%): -4.190307948688653
Rule of 40 score: -4.190307948688653
Financial ratios for MENE.V — annual report dated 2022-12-31
Total revenue: 19787994.852941174
Gross profit: 4884832.352941176
Operating income: -231305.88235294115
Net income: -1076078.6764705882
Capital expenditures: 536719.8529411764
Operating cash flow: 3455802.205882353
Depreciation & amortization: 131969.11764705883
Net tangible assets: 11851518.38235294
Owner earnings: -1480829.4117647058
Return on net tangible assets (%): -12.494849722966125
Buffett classification: The Gruesome
Stock price: 0.3676470588235294
Shares outstanding: 150418163
Book value: 12844945.58823529
P/B ratio: 4.30525725786167
Market cap (USD): 55300795.22058823
Debt to equity: 0.707171612363435
Current ratio: 2.113229246602041
Quick ratio: 1.0101978936115001
Interest coverage ratio: -0.9440008162358922
COGS to revenue (%): 75.31416199951597
R&D to revenue (%): 1.9427740519885182
SG&A to revenue (%): 22.43259272658374
Free cash flow (dilution-adjusted): 2822104.411764706
Buyback yield (%): 0
Retained earnings: -14664038.970588233
Inventory turnover: 1.3604119165159259
Receivables turnover: 210.90818109859794
Capitalized R&D asset: 719127.4073645207
ROCI (R&D-adjusted, %): -1.003267533805079
Rosenberg metric: -0.5024312347039499
FCF margin (%): 14.261699746426023
Revenue growth (%): -6.13487337034579
Rule of 40 score: 8.126826376080233
Financial ratios for MENE.V — annual report dated 2023-12-31
Total revenue: 17643828.787878785
Gross profit: 4416261.363636363
Operating income: -911863.6363636364
Net income: -1505862.121212121
Capital expenditures: 10296.21212121212
Operating cash flow: -647442.4242424242
Depreciation & amortization: 163759.0909090909
Net tangible assets: 11725426.515151514
Owner earnings: -1352399.2424242424
Return on net tangible assets (%): -11.533902333332453
Buffett classification: The Gruesome
Stock price: 0.22727272727272727
Shares outstanding: 150418163
Book value: 12107384.848484848
P/B ratio: 2.8235615340699907
Market cap (USD): 34185946.13636363
Debt to equity: 0.04807008595054809
Current ratio: 10.04330803871567
Quick ratio: 5.338317418279046
Interest coverage ratio: -3.1957243785294986
COGS to revenue (%): 74.96993755306495
R&D to revenue (%): 0.50123113695775
SG&A to revenue (%): 28.768866477222225
Free cash flow (dilution-adjusted): -1219864.393939394
Buyback yield (%): 0
Retained earnings: -16614265.909090908
Inventory turnover: 2.295278352168832
Receivables turnover: 150.9495427412194
Capitalized R&D asset: 510856.4954682302
ROCI (R&D-adjusted, %): -8.76567426774403
Rosenberg metric: -1.2188529520029248
FCF margin (%): -6.913830374376759
Revenue growth (%): -10.835691443207002
Rule of 40 score: -17.749521817583762
Financial ratios for MENE.V — quarterly report dated 2024-09-30
Total revenue: 3991181.4814814813
Gross profit: 1332913.3333333333
Operating income: 971037.7777777778
Net income: 976057.037037037
Capital expenditures: 1037.7777777777776
Operating cash flow: -908389.6296296295
Depreciation & amortization: 39029.62962962963
Net tangible assets: 11726210.37037037
Owner earnings: 1014048.8888888889
Return on net tangible assets (%): 8.647711893786028
Capex to operating income (%): 0.10687305906395676
Buffett classification: The Great
Stock price: 0.1037037037037037
P/E ratio: 3.995391666546506
Shares outstanding: 150418163
Book value: 12033163.703703703
P/B ratio: 1.2963274656195525
Market cap (USD): 15598920.607407408
Debt to equity: 0.043644197877581656
Current ratio: 11.723683425861507
Quick ratio: 4.156682616535802
Effective tax rate (%): 0
Interest coverage ratio: 36.89145607024259
COGS to revenue (%): 66.60353984107556
R&D to revenue (%): 0.7506549160695941
SG&A to revenue (%): 7.3383264400497765
Free cash flow (dilution-adjusted): -166107.4074074073
Buyback yield (%): 0
Retained earnings: -16186047.407407407
Inventory turnover: 0.33668770545372867
Receivables turnover: 14.172484086485351
Capitalized R&D asset: 29959.999999999996
ROCI (R&D-adjusted, %): 7.942632731935811
FCF margin (%): -4.161860546259854
Rule of 40 score: -4.161860546259854
Financial ratios for MENE.V — annual report dated 2024-12-31
Total revenue: 18041808.39160839
Gross profit: 5222276.923076923
Operating income: -896477.6223776224
Net income: -695058.041958042
Capital expenditures: 84497.2027972028
Operating cash flow: -343764.3356643357
Depreciation & amortization: 313809.09090909094
Net tangible assets: 12143378.321678322
Owner earnings: -465746.1538461538
Return on net tangible assets (%): -3.83539194372875
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 150418163
Book value: 12426537.762237761
P/B ratio: 1.0157699135771296
Market cap (USD): 12622503.188811189
Debt to equity: 0.04081587403542914
Current ratio: 7.084060780387892
Quick ratio: 3.004453982936034
Interest coverage ratio: -7.844302620146121
COGS to revenue (%): 71.05458161552193
R&D to revenue (%): 0.5408610753593073
SG&A to revenue (%): 32.55382815965993
Free cash flow (dilution-adjusted): -1741502.097902098
Buyback yield (%): 0
Retained earnings: -16031303.496503497
Inventory turnover: 1.6547506472977418
Receivables turnover: 48.105478662805766
Capitalized R&D asset: 283697.3722233649
ROCI (R&D-adjusted, %): -7.547400407386458
Rosenberg metric: 9.114073965713565
FCF margin (%): -9.652591692039616
Revenue growth (%): 2.2556306146147573
Rule of 40 score: -7.396961077424859
Financial ratios for MENE.V — quarterly report dated 2024-12-31
Total revenue: 6376910.48951049
Gross profit: 1986087.4125874126
Operating income: -847073.4265734266
Net income: -750769.2307692308
Capital expenditures: 83517.48251748252
Operating cash flow: 1534481.8181818184
Depreciation & amortization: 203080.41958041958
Net tangible assets: 12143378.321678322
Owner earnings: -631206.2937062937
Return on net tangible assets (%): -5.197946378558149
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 150418163
Book value: 12426537.762237761
P/B ratio: 1.0157699135771296
Market cap (USD): 12622503.188811189
Debt to equity: 0.04081587403542914
Current ratio: 7.084060780387892
Quick ratio: 3.004453982936034
Interest coverage ratio: -41.75076689759763
COGS to revenue (%): 68.85502131707246
R&D to revenue (%): 0.44073998610809845
SG&A to revenue (%): 43.405184920860684
Free cash flow (dilution-adjusted): 176792.3076923075
Buyback yield (%): 0
Retained earnings: -16031303.496503497
Inventory turnover: 0.5667693352556388
Receivables turnover: 17.00297025826144
Capitalized R&D asset: 48178.7944055944
ROCI (R&D-adjusted, %): -6.514301495486594
Rosenberg metric: 21.801538025837097
FCF margin (%): 2.772381829462979
Revenue growth (%): 59.77500695216327
Rule of 40 score: 62.547388781626246
Financial ratios for MENE.V — quarterly report dated 2025-03-31
Total revenue: 5131995.104895105
Gross profit: 1203689.5104895106
Operating income: -172760.83916083915
Net income: -146770.62937062938
Capital expenditures: 33595.804195804194
Operating cash flow: -677613.986013986
Depreciation & amortization: 83644.05594405594
Net tangible assets: 12205507.692307692
Owner earnings: -96722.37762237762
Return on net tangible assets (%): -0.792448622873223
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 150418163
Book value: 12463328.671328673
P/B ratio: 1.1815666671903475
Market cap (USD): 14726253.720279723
Debt to equity: 0.03898794561499582
Current ratio: 11.908746909584588
Quick ratio: 4.995220113729912
Interest coverage ratio: -12.582021899668959
COGS to revenue (%): 76.54538856942045
R&D to revenue (%): 0.4912006167805348
SG&A to revenue (%): 25.55229750885471
Free cash flow (dilution-adjusted): -910537.7622377623
Buyback yield (%): 0
Retained earnings: -16178074.125874126
Inventory turnover: 0.5334186363513351
Receivables turnover: 10.099669296605025
Capitalized R&D asset: 53925.93986013986
ROCI (R&D-adjusted, %): -1.3600159628341464
Rosenberg metric: -27.83779950735239
FCF margin (%): -17.74237394282108
Revenue growth (%): -19.522233951114284
Rule of 40 score: -37.26460789393536
Financial ratios for MENE.V — quarterly report dated 2025-06-30
Total revenue: 4108275.912408759
Gross profit: 1127208.7591240874
Operating income: -285329.1970802919
Net income: -257466.4233576642
Capital expenditures: 1036.4963503649635
Operating cash flow: 588468.613138686
Depreciation & amortization: 87642.33576642335
Net tangible assets: 12272890.510948904
Owner earnings: -170860.58394160582
Return on net tangible assets (%): -1.3921788334148137
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
Shares outstanding: 150418163
Book value: 12503435.03649635
P/B ratio: 1.2293580998996714
Market cap (USD): 15371199.138686132
Debt to equity: 0.036822465020707296
Current ratio: 11.068007994686885
Quick ratio: 4.694303285301007
Interest coverage ratio: -41.035166911610325
COGS to revenue (%): 72.56248647469288
R&D to revenue (%): 0.5653356283862128
SG&A to revenue (%): 32.74135277589939
Free cash flow (dilution-adjusted): 378717.5182481752
Buyback yield (%): 0
Retained earnings: -17144069.34306569
Inventory turnover: 0.40071452476852076
Receivables turnover: 20.785111545236663
Capitalized R&D asset: 49390.01597672401
ROCI (R&D-adjusted, %): -2.2254976789640333
Rosenberg metric: -3.0339401479292936
FCF margin (%): 9.21840514908664
Revenue growth (%): -19.94778193591574
Rule of 40 score: -10.729376786829098
Financial ratios for MENE.V — quarterly report dated 2025-09-30
Total revenue: 4248273.381294964
Gross profit: 1290232.3741007196
Operating income: 6392.805755395684
Net income: 42419.424460431655
Capital expenditures: 3275.539568345324
Operating cash flow: 604187.0503597122
Depreciation & amortization: 86443.88489208634
Net tangible assets: 12471587.050359713
Owner earnings: 125587.76978417268
Return on net tangible assets (%): 1.0069910852328163
Capex to operating income (%): 51.237902318253425
Buffett classification: The Good
Stock price: 0.11510791366906475
P/E ratio: 102.04240828994455
Shares outstanding: 150418163
Book value: 12678456.834532376
P/B ratio: 1.3656489229591577
Market cap (USD): 17314320.92086331
Debt to equity: 0.03483595778371003
Current ratio: 9.657047439852553
Quick ratio: 4.357577817165062
Interest coverage ratio: 0.981878453038674
COGS to revenue (%): 69.62925267988689
R&D to revenue (%): 0.5443599600345465
SG&A to revenue (%): 28.65128448290461
Free cash flow (dilution-adjusted): 417623.02158273384
Buyback yield (%): 0
Retained earnings: -16854972.661870506
Inventory turnover: 0.4031562594435889
Receivables turnover: 16.341638231867453
Capitalized R&D asset: 47005.785299665935
ROCI (R&D-adjusted, %): 0.043330963385141225
Rosenberg metric: 7.019150586693048
FCF margin (%): 9.830417774466142
Revenue growth (%): 3.407693929790657
Rule of 40 score: 13.238111704256799
Financial ratios for MENE.V — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1094890510948905
Shares outstanding: 150418163
Market cap (USD): 16469141.934306568
Buyback yield (%): 0
Capitalized R&D asset: 23158.78317491992
Rule of 40 score: 0
Financial ratios for MENE.V — annual report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1094890510948905
Shares outstanding: 150418163
Market cap (USD): 16469141.934306568
Buyback yield (%): 0
Capitalized R&D asset: 94563.34965034967
Rule of 40 score: 0
Financial ratios for MLOCT.PA — annual report dated 2021-12-31
Total revenue: 75928.40909090909
Gross profit: 62265.90909090909
Operating income: -1253469.3181818181
Net income: -1148377.2727272727
Capital expenditures: 0
Depreciation & amortization: 560553.4090909091
Net tangible assets: -1341075
Owner earnings: -587823.8636363636
Buffett classification: The Gruesome
Stock price: 0.8977272727272728
Shares outstanding: 127127197
Book value: -722552.2727272727
Market cap (USD): 114125551.85227273
Debt to equity: -2.7109237142326914
Current ratio: 0.6331234559483703
Quick ratio: 0.3030212275437464
Interest coverage ratio: -124.94936565473492
COGS to revenue (%): 17.993923702051873
Buyback yield (%): 0
Retained earnings: -7514193.181818182
Inventory turnover: 0.02320867733896483
Receivables turnover: 1.1009012571466232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -860.1876257466829
Rule of 40 score: 0
Financial ratios for MLOCT.PA — annual report dated 2022-12-31
Total revenue: 23192.55319148936
Gross profit: -58651.063829787236
Operating income: -766513.8297872341
Net income: -853965.9574468086
Capital expenditures: 0
Depreciation & amortization: 255555.3191489362
Net tangible assets: -2004645.7446808512
Owner earnings: -598410.6382978724
Buffett classification: The Gruesome
Stock price: 0.4468085106382979
Shares outstanding: 127127197
Book value: -1530397.8723404254
Market cap (USD): 56801513.55319149
Debt to equity: -1.873412142858136
Current ratio: 0.438660528830091
Quick ratio: 0.15700557261480727
Interest coverage ratio: -156.16016471608148
COGS to revenue (%): 352.887482225586
Buyback yield (%): 0
Retained earnings: -7888529.787234043
Inventory turnover: 0.109280760915576
Receivables turnover: 0.30821540158059174
Capitalized R&D asset: 0
Revenue growth (%): -69.45470941749758
Rule of 40 score: -69.45470941749758
Financial ratios for MLOCT.PA — annual report dated 2023-12-31
Total revenue: 254831.1111111111
Gross profit: -77722.22222222222
Operating income: -878581.1111111111
Net income: -1974516.6666666665
Capital expenditures: 0
Depreciation & amortization: 272792.2222222222
Net tangible assets: -94302.22222222222
Owner earnings: -1701724.4444444443
Buffett classification: The Gruesome
Stock price: 0.2333333333333333
Shares outstanding: 127127197
Book value: 3487.777777777752
P/B ratio: 8504.845928639756
Market cap (USD): 29663012.63333333
Debt to equity: 112.57438674737261
Current ratio: 1.2649576997153777
Quick ratio: 1.1724727920962397
Interest coverage ratio: -228.66483516483518
COGS to revenue (%): 130.49950293876554
Buyback yield (%): 0
Retained earnings: -8862004.444444444
Inventory turnover: 7.482449999999999
Receivables turnover: 3.706993809500719
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -233.65345121551223
Revenue growth (%): 998.762645954059
Rule of 40 score: 998.762645954059
Financial ratios for MUFIN.NS — annual report dated 2024-03-31
Total revenue: 10825110.92457129
Gross profit: 3542738.9375224845
Operating income: 2134008.8739657034
Net income: 1926118.239597074
Capital expenditures: 45125.31478594556
Operating cash flow: -43014702.002638206
Depreciation & amortization: 274649.2385178079
Net tangible assets: 29127209.49754167
Owner earnings: 2155642.1633289363
Return on net tangible assets (%): 7.400785040911222
Capex to operating income (%): 2.1145795285324938
Buffett classification: The Great
Stock price: 1.5996880998080614
P/E ratio: 164.57852247006437
Shares outstanding: 198162188
Book value: 29271795.17927809
P/B ratio: 10.829458597740356
Market cap (USD): 316997693.9755278
Debt to equity: 2.622198506744231
Current ratio: 1.617237233036137
Quick ratio: 1.617237233036137
Effective tax rate (%): 24.35050866616428
Interest coverage ratio: 41.51038021926755
COGS to revenue (%): 67.27295487124269
SG&A to revenue (%): 3.8019022804767
Free cash flow (dilution-adjusted): -43278126.87372587
Buyback yield (%): 0
Retained earnings: 3696306.511572131
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.237951546904036
FCF margin (%): -399.7938420703973
Revenue growth (%): 168.6009970162123
Rule of 40 score: -231.19284505418503
Financial ratios for MUFIN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 30920556.61729575
Buffett classification: The Gruesome
Stock price: 1.341614906832298
Shares outstanding: 198162188
Book value: 31000537.50597228
P/B ratio: 8.57589470311883
Market cap (USD): 265857345.3913043
Debt to equity: 2.6113074654239394
Current ratio: 2110.687294117647
Quick ratio: 2110.687294117647
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUFIN.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2340599137428605
Shares outstanding: 198162188
Market cap (USD): 244544012.63037652
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUFIN.NS — annual report dated 2025-03-31
Total revenue: 21145873.275660507
Gross profit: 5543593.64040215
Operating income: 2911257.8910451247
Net income: 2292202.478372691
Capital expenditures: 100806.64016834229
Operating cash flow: -17834019.172317043
Depreciation & amortization: 387000.2338087444
Net tangible assets: 31483247.603460368
Owner earnings: 2578396.072013093
Return on net tangible assets (%): 8.189739840338765
Capex to operating income (%): 3.4626489284380537
Buffett classification: The Great
Stock price: 0.817014820865912
P/E ratio: 70.63138883182617
Shares outstanding: 198162188
Book value: 31475087.67827916
P/B ratio: 5.143796458522489
Market cap (USD): 161901444.5312172
Debt to equity: 2.6516493406017503
Current ratio: 1.7677026457369074
Quick ratio: 1.7677026457369074
Effective tax rate (%): 25.788288288288285
Interest coverage ratio: 36.02328945465066
COGS to revenue (%): 73.78404018535862
SG&A to revenue (%): 2.7816507796804326
Free cash flow (dilution-adjusted): -17934825.812485386
Buyback yield (%): 0
Retained earnings: 5437163.899929857
Receivables turnover: 15.892615208891621
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.057908904850673
FCF margin (%): -84.81477959639942
Revenue growth (%): 95.34093851789285
Rule of 40 score: 10.526158921493433
Financial ratios for MUFIN.NS — quarterly report dated 2025-03-31
Total revenue: 5765758.70937573
Gross profit: 1282885.1999064763
Operating income: 477542.67009586154
Net income: 421416.88099134905
Capital expenditures: 0
Depreciation & amortization: 97474.86555997193
Net tangible assets: 31483247.603460368
Owner earnings: 518891.746551321
Return on net tangible assets (%): 1.648151909507229
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.817014820865912
P/E ratio: 96.0458941217288
Shares outstanding: 198162188
Book value: 31475087.67827916
P/B ratio: 5.143796458522489
Market cap (USD): 161901444.5312172
Debt to equity: 2.6516493406017503
Current ratio: 1.7677026457369074
Quick ratio: 1.7677026457369074
Effective tax rate (%): 18.327372634470997
COGS to revenue (%): 77.74993258354066
Buyback yield (%): 0
Retained earnings: 5437163.899929857
Receivables turnover: 4.333374335544524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.665631395758105
Rule of 40 score: 0
Financial ratios for MUFIN.NS — quarterly report dated 2025-06-30
Total revenue: 5687362.508776036
Gross profit: 1755616.6627662065
Operating income: 472747.484203136
Net income: 407500.58506903815
Capital expenditures: 0
Depreciation & amortization: 59782.354317809506
Owner earnings: 467282.93938684766
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8963257664404399
P/E ratio: 214.2769121306885
Shares outstanding: 198162188
Market cap (USD): 177617875.03861454
Effective tax rate (%): 25.53282182438193
COGS to revenue (%): 69.13126849120034
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.3596857681923669
Rule of 40 score: -1.3596857681923669
Financial ratios for MUFIN.NS — quarterly report dated 2025-09-30
Total revenue: 5935129.650507328
Gross profit: 1999729.425028185
Operating income: 833100.3382187147
Net income: 648602.0293122886
Capital expenditures: 0
Depreciation & amortization: 78568.20744081172
Net tangible assets: 35807598.64712514
Owner earnings: 727170.2367531003
Return on net tangible assets (%): 2.0307707420404806
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9922209695603157
P/E ratio: 133.07484532240287
Shares outstanding: 198162188
Book value: 35734633.59639235
P/B ratio: 5.502244140189078
Market cap (USD): 196620678.30755356
Debt to equity: 2.723965836104921
Current ratio: 1287.383937424259
Quick ratio: 1287.383937424259
Effective tax rate (%): 26.704180275187245
COGS to revenue (%): 66.30689567401025
Buyback yield (%): 0
Receivables turnover: 7.013295321325803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5971984622963918
Revenue growth (%): 4.356450663184707
Rule of 40 score: 4.356450663184707
Financial ratios for MUFIN.NS — quarterly report dated 2025-12-31
Total revenue: 6135535.256767294
Gross profit: 2000935.7246296091
Operating income: 1011429.2079759386
Net income: 780360.922357135
Capital expenditures: 0
Depreciation & amortization: 76863.09457502507
Owner earnings: 857224.01693216
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.2888492814971595
P/E ratio: 113.11546511417932
Shares outstanding: 198162188
Market cap (USD): 255401193.62370503
Effective tax rate (%): 25.421581569646122
COGS to revenue (%): 67.38775606541186
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.3766003113821754
Rule of 40 score: 3.3766003113821754
Financial ratios for MUKANDLTD.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7599894500857183
Shares outstanding: 144495563
Market cap (USD): 254310666.46419626
Buyback yield (%): 0.17527140509263367
Retained earnings: 32357905.842015035
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUKANDLTD.NS — annual report dated 2023-03-31
Total revenue: 675479902.5578563
Gross profit: 58159561.51035323
Operating income: -26813641.900121804
Net income: 20923264.311814863
Capital expenditures: 75475030.45066991
Operating cash flow: 12900121.80267966
Depreciation & amortization: 6380024.360535932
Net tangible assets: 100060901.33982949
Owner earnings: -48171741.77831912
Return on net tangible assets (%): -48.14242239805234
Buffett classification: The Gruesome
Stock price: 1.6503045066991475
P/E ratio: 11.396963459582024
Shares outstanding: 144495563
Book value: 103992691.83922046
P/B ratio: 2.293061893095411
Market cap (USD): 238461678.8169306
Debt to equity: 1.7557099018482514
Current ratio: 3.064750858789199
Quick ratio: 1.1571307206441839
Effective tax rate (%): 0.28443722064201543
Interest coverage ratio: -1.2493757094211124
COGS to revenue (%): 91.38989016695848
SG&A to revenue (%): 0.2643494317208499
Free cash flow (dilution-adjusted): 5475030.450669915
Buyback yield (%): 0
Retained earnings: 52140073.081607796
Inventory turnover: 3.271178236034466
Receivables turnover: 11.98006091896913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.305805666167855
FCF margin (%): 0.8105393557880083
Rule of 40 score: 0.8105393557880083
Financial ratios for MUKANDLTD.NS — annual report dated 2024-03-31
Total revenue: 618215613.3828996
Gross profit: 87982971.57932606
Operating income: 28620937.76232162
Net income: 12453531.59851301
Capital expenditures: 7533277.371387457
Operating cash flow: 10937762.321621297
Depreciation & amortization: 5962345.604988608
Net tangible assets: 108443458.44825518
Owner earnings: 10882599.832114164
Return on net tangible assets (%): 10.035275513927749
Capex to operating income (%): 26.320861440482673
Buffett classification: The Good
Stock price: 1.7389635316698657
P/E ratio: 20.17680788436818
Shares outstanding: 144495563
Book value: 108499820.12231681
P/B ratio: 2.315879549494502
Market cap (USD): 251272514.54510558
Debt to equity: 1.6395366829505518
Current ratio: 3.7246825545755926
Quick ratio: 1.238099706011134
Effective tax rate (%): 18.118741622644485
Interest coverage ratio: 1.8259505776145666
COGS to revenue (%): 85.76823851182279
SG&A to revenue (%): 0.21899792446608343
Free cash flow (dilution-adjusted): 3361314.306271735
Buyback yield (%): 0
Retained earnings: 62304832.71375465
Inventory turnover: 2.7806769300430156
Receivables turnover: 9.672414116587554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.98393668376183
FCF margin (%): 0.5437122960836421
Revenue growth (%): -8.477571125079013
Rule of 40 score: -7.933858828995371
Financial ratios for MUKANDLTD.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 108649068.32298137
Buffett classification: The Gruesome
Stock price: 1.942068800764453
Shares outstanding: 144495563
Book value: 112301720.01911134
P/B ratio: 2.498807005836054
Market cap (USD): 280620324.7511945
Debt to equity: 1.5741286335740647
Current ratio: 1.1485789291378776
Quick ratio: 0.3447988259530017
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0